Season 3 Episode 9- Dr. Ivo Abraham- Trilaciclib and the economic value of multilineage myeloprotection and other work
On today’s episode of The PQI Podcast we welcome Ivo Abraham, PhD, RN. Dr. Abraham is a professor in the Department of Pharmacy Practice at the University of Arizona. For the past decade Dr. Abraham’s research has focused mainly on clinical outcomes and effectiveness research, in particular how variability in (drug-centric) treatment regimens is associated with variability in patient outcomes. He has (co-)authored more than 260+ articles and more than 60+ chapters, and has (co-)edited 29 books, monographs, and journal issues.
Today we discuss his article on Trilaciclib and the economic value of multilineage myeloprotection, his personal story, and his other work in oncology.
You can access the article discussed in the podcast here.
You can access the Trilaciclib PQI here.